These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3681540)

  • 1. [SCC antigen to squamous cell carcinoma of the head and neck region].
    Kida A; Furusaka T; Koizumi F; Iida H; Yamada K
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Aug; 90(8):1223-8. PubMed ID: 3681540
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of cancer/testis (CT) antigens in squamous cell carcinoma of the head and neck: evaluation as markers of squamous dysplasia.
    Piotti KC; Scognamiglio T; Chiu R; Chen YT
    Pathol Res Pract; 2013 Nov; 209(11):721-6. PubMed ID: 24011616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study on the measurement of squamous cell carcinoma (SCC)--related antigen in SCC].
    Fukunaga M; Otsuka N; Sone T; Nagai K; Muranaka A; Furukawa T; Yanagi M; Yanagimoto S; Tomomitsu T; Morita R
    Gan No Rinsho; 1985 Dec; 31(15):1885-8. PubMed ID: 3842935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spindle-cell squamous carcinoma of head and neck region: a clinicopathologic and immunohistochemical study of eight cases.
    Leonardi E; Dalri P; Pusiol T; Valdagni R; Piscioli F
    ORL J Otorhinolaryngol Relat Spec; 1986; 48(5):275-81. PubMed ID: 2431373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
    Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
    Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck.
    Wolf GT; Carey TE; Schmaltz SP; McClatchey KD; Poore J; Glaser L; Hayashida DJ; Hsu S
    J Natl Cancer Inst; 1990 Oct; 82(19):1566-72. PubMed ID: 2119437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
    Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN
    J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.
    Kienstra MA; Neel HB; Strome SE; Roche P
    Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma radioimmunoassay in squamous cell carcinoma of the head and neck.
    Cook DW; Winek T; Baker H; Deveney CW; Sasaki T
    Am J Surg; 1989 May; 157(5):503-4. PubMed ID: 2712209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
    Eibling DE; Johnson JT; Wagner RL; Su S
    Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma-antigen for detection of squamous cell and mucoepidermoid carcinoma after primary treatment: a preliminary report.
    Yoshimura Y; Oka M; Harada T
    J Oral Maxillofac Surg; 1990 Dec; 48(12):1288-92; discussion 1292-3. PubMed ID: 2231147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncofetal antigen expression in head and neck carcinoma.
    Gussack GS
    Laryngoscope; 1992 Feb; 102(2):168-76. PubMed ID: 1738289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of serum squamous cell carcinoma-related antigen levels in patients with malignant neoplasms].
    Jinnouchi S; Hoshi H; Mori Y; Harada K; Onoe K; Nagamachi S; Futami S; Ebihara H; Watanabe K; Tahara Y
    Radioisotopes; 1986 Dec; 35(12):642-4. PubMed ID: 3823498
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
    Wolf GT; Carey TE
    J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs.
    Mino N; Iio A; Hamamoto K
    Cancer; 1988 Aug; 62(4):730-4. PubMed ID: 2840187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum SCC-Ag in head and neck squamous cell carcinoma.
    Palermo F; Carniato A; Fede A; Boccaletto F; Marchiori C
    Int J Biol Markers; 1990; 5(3):118-20. PubMed ID: 2286775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the nature of herpesvirus-induced tumour-associated antigens induced by herpes simplex virus type 1 and further analysis of their relationship with squamous-cell carcinomas of the head and neck region.
    Hollinshead AC; Chretien PB; Tarpley JL
    IARC Sci Publ (1971); 1975; (11 Pt 2):307-11. PubMed ID: 191376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCC antigen measured in malignant and nonmalignant diseases.
    Molina R; Filella X; Torres MD; Ballesta AM; Mengual P; Cases A; Balaque A
    Clin Chem; 1990 Feb; 36(2):251-4. PubMed ID: 2302769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of tumor burden with in vitro lymphocyte reactivity and antibodies to herpesvirus tumor-associated antigens in head and neck squamous carcinoma.
    Silverman NA; Alexander JC; Hollinshead AC; Chretien PB
    Cancer; 1976 Jan; 37(1):135-40. PubMed ID: 174796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the changes of antitumor immune response during lymph node metastasis in head and neck squamous cell carcinoma.
    Kumagai K; Hamada Y; Gotoh A; Kobayashi H; Kawaguchi K; Horie A; Yamada H; Suzuki S; Suzuki R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Sep; 110(3):341-50. PubMed ID: 20598595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.